Details of the Drug
General Information of Drug (ID: DMOGV9F)
Drug Name |
NSC-2113
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
1,4-Diethoxybenzene; 122-95-2; Benzene, 1,4-diethoxy-; p-Diethoxybenzene; Hydroquinone diethyl ether; Benzene, p-diethoxy-; NSC-2113; 1,4-diethoxy-benzen; UNII-C6Y51501JB; CHEMBL219898; VWGNFIQXBYRDCH-UHFFFAOYSA-N; C6Y51501JB; Benzene,4-diethoxy-; NSC2113; NSC 2113; EINECS 204-585-5; 1,4-diethoxybenzol; hydroquinonedlethylether; ACMC-209ans; AI3-09458; AC1Q37UB; AC1L26YB; KSC174M8J; SCHEMBL124015; Benzene, p-diethoxy- (8CI); Jsp001542; DTXSID9059549; CTK0H4684; KS-00000WIN; MolPort-001-759-994; ZINC394919; NSC68808; SBB060362
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 166.22 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | 2.5 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 4 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 0 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 2 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||